Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus
Authors:
Open Access
- 21 October 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 57 (1) , 150-151
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Comment on: Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignanciesJournal of Antimicrobial Chemotherapy, 2005
- Successful treatment with linezolid of septic shock secondary to methicillin-resistant Staphylococcus aureus arthritisJournal of Antimicrobial Chemotherapy, 2005
- Subinhibitory Concentrations of Linezolid Reduce Staphylococcus aureus Virulence Factor ExpressionAntimicrobial Agents and Chemotherapy, 2004
- A Case of Invasive Group A Streptococcus Infection Which was Successfully Treated with LinezolidKansenshogaku Zasshi, 2004
- LinezolidPenetration into Bone and Joint Tissues Infected withMethicillin-ResistantStaphylococciAntimicrobial Agents and Chemotherapy, 2003
- Influences of Linezolid, Penicillin, and Clindamycin, Alone and in Combination, on Streptococcal Pyrogenic Exotoxin A ReleaseAntimicrobial Agents and Chemotherapy, 2003
- Virulence factor expression by Gram-positive cocci exposed to subinhibitory concentrations of linezolidJournal of Antimicrobial Chemotherapy, 2002